Top News arrow News / Infomails
News and Infomails from AHRP
DSM5 Revisions Print E-mail
Wednesday, 10 February 2010

"Anything you put in that book, any little change you make, has huge implications not only for psychiatry but for pharmaceutical marketing, research, for the legal system, for who's considered to be normal or not, for who's considered disabled," said Dr. Michael First, professor of psychiatry at Columbia University who edited the DSM4l but is not involved in the DSM5.

Read more...
 
Criminal Drug Marketing Remains an Issue Print E-mail
Friday, 29 January 2010
Read more...
 
Unethical US Gov Blood Experiment vs. Canadian Version Print E-mail
Thursday, 28 January 2010
The Alliance for Human Research Protection (AHRP) has recently obtained further information reaffirming our original concerns and raising new ones about the safety and ethics of a government sponsored clinical trial.
Read more...
 
An Ethically Dubious Blood Experiment: RECESS Print E-mail
Friday, 22 January 2010

AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.

 

Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Results 155 - 168 of 753
(C) 2012 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]